Physician profile
Aroucha Vickers
NPI 1184062267
$6,961.83
in general payments reported to CMS, 2019-2025
43 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2020: $130 · 2021: $424 · 2022: $890 · 2023: $1,529 · 2024: $1,824 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,654 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,654.04 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,376.04 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $851.03 | 2019-2025 | |
| Pfizer INC. | $548.03 | 2019-2025 | |
| Amgen INC. | $520.05 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $319.99 | 2019-2024 | Ultomiris, Soliris |
| Genentech USA, INC. | $290.57 | 2019-2025 | Enspryng, Ocrevus Zunovo |
| Penumbra, INC. | $250.70 | 2023-2025 | Artemis, Red 72 |
| Allergan, INC. | $218.66 | 2019-2022 | |
| Horizon Therapeutics Plc | $209.45 | 2020-2023 | Tepezza, Uplizna |
| Ucb, INC. | $192.68 | 2019-2025 | Rystiggo, Briviact |
| Catalyst Pharmaceuticals, INC. | $99.21 | 2022-2025 | |
| Abbott Laboratories | $97.64 | 2019-2023 | Amplatzer Amulet |
| Argenx US, INC. | $90.07 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Sunovion Pharmaceuticals INC. | $84.66 | 2021-2022 | |
| Livanova USA, INC. | $80.01 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aroucha Vickers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.